611 related articles for article (PubMed ID: 15603095)
1. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
[TBL] [Abstract][Full Text] [Related]
2. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
4. Time to positive culture and identification for Candida blood stream infections.
Fernandez J; Erstad BL; Petty W; Nix DE
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):402-7. PubMed ID: 19446982
[TBL] [Abstract][Full Text] [Related]
5. Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata.
Seyfarth F; Schliemann S; Elsner P; Hipler UC
Int J Pharm; 2008 Apr; 353(1-2):139-48. PubMed ID: 18164151
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of Candida albicans by human vaginal epithelial cells.
Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
[TBL] [Abstract][Full Text] [Related]
7. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans: the estrogen target for vaginal colonization.
Tarry W; Fisher M; Shen S; Mawhinney M
J Surg Res; 2005 Dec; 129(2):278-82. PubMed ID: 16111702
[TBL] [Abstract][Full Text] [Related]
9. [Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis].
Buitrón García R; Romero Cabello R; Cruz Talonia F; Bonifaz A; Zarama Marquez F
Ginecol Obstet Mex; 2002 Sep; 70():431-6. PubMed ID: 12448051
[TBL] [Abstract][Full Text] [Related]
10. Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis.
Fodor E; Dósa E; Nagy A; Nagy E; Ferenczy L
Acta Microbiol Immunol Hung; 2002; 49(1):59-68. PubMed ID: 12073826
[TBL] [Abstract][Full Text] [Related]
11. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
[TBL] [Abstract][Full Text] [Related]
12. Oral epithelium-Candida glabrata interactions in vitro.
Li L; Dongari-Bagtzoglou A
Oral Microbiol Immunol; 2007 Jun; 22(3):182-7. PubMed ID: 17488444
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
[TBL] [Abstract][Full Text] [Related]
14. Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
Novikova N; Rodrigues A; Mårdh PA
Infect Dis Obstet Gynecol; 2002; 10(2):89-92. PubMed ID: 12530485
[TBL] [Abstract][Full Text] [Related]
15. Human oral keratinocyte E-cadherin degradation by Candida albicans and Candida glabrata.
Pärnänen P; Meurman JH; Samaranayake L; Virtanen I
J Oral Pathol Med; 2010 Mar; 39(3):275-8. PubMed ID: 20359311
[TBL] [Abstract][Full Text] [Related]
16. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
17. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
Abu-Elteen KH
Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
[TBL] [Abstract][Full Text] [Related]
19. [Anti-candidal activity of clinical Pseudomonas aeruginosa strains and in vitro inhibition of Candida biofilm formation].
Keçeli Özcan S; Dündar D; Sönmez Tamer G
Mikrobiyol Bul; 2012 Jan; 46(1):39-46. PubMed ID: 22399170
[TBL] [Abstract][Full Text] [Related]
20. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
